食品伙伴网报道，根据美国营养成分网8月20日消息称，中国严厉的安全规则和成熟的消费者市场已经促使该国内的海洋生物产业上加大了投资。国外的保健品公司将中国市场作为“机遇之窗”。
海南魁北克海洋渔业有限公司（HQ Sustainable Maritime Industries）上周已确认对其已被中国认证的Jiahua子公司注入了1150万美元的资金，以便抓住这个“机遇之窗”。该企业称，在中国，由于“宏观调控和社会经济学发展趋势相结合，为之提供了广阔的企业对企业和企业对消费者的发展前景，而这些则体现在来自罗非鱼和非濒危鲨鱼的的副产品，如鲨鱼软骨胶囊、鲨鱼鱼肝油等产品。
HQ称，中国市场的机遇是由新的安全立法所驱动的。将直接或间接向消费者销售不合格产品视为刑事犯罪。而此举导致中国国内1/3的保健品生产商停业。并且中国目前已经成为了一个老龄化社会，到2050年，根据世卫组织的报告，中国24%的人口将65岁以上，这意味着将有3亿名65岁以上的老人。这个市场是巨大的。
原文报道：
Nutraceutical firm targets Chinese ‘window of opportunity’
20-Aug-2010The tightening of safety rules in China and a ripe consumer market has prompted heavy investment in the country from a US-based producer of marine-biomass products.
HQ Sustainable Maritime Industries last week confirmed an injection of $11.5m into its Jiahua subsidiary in order to develop the “immediate window of opportunity” it has identified in the country.
According to the firm, a combination of “macro-regulatory and socio-economic trends” in China provide a fertile landscape for the growth of both its B2B and B2C operations, which are focused on the supply of fish by-products from tilapia and non-endangered shark. These include shark cartilage capsules and shark liver oil products.
Competitors down, consumers up
HQ said the Chinese market opportunity is driven by new safety legislation which “made it a criminal offence to manufacture or certify substandard products for direct or indirect human consumption. This led to the closure of almost one-third of the nutraceutical manufacturers in China”.
In addition, the firm believes the population demographics are currently strong for its business, with a key target for the company’s products being elderly consumers.
It notes “an aging China population, with an estimated 24 percent to be over the age of 65 by 2050, according to the World Health Organization. This will represent roughly 300 million people over the age of 65”.
Vertical integration
HQ said it has raised $11.5m in equity financing “to be fully utilized to develop this opportunity”.
The firm says its long-term goal is to “become the world leader in vertically integrated production, processing and raising of all natural tilapia products”.
“This includes the use of tilapia by-products to increase the range and variety of our marine bio and healthcare products, with a primary focus on increasing our own seafood products.”
原文地址：http://www.nutraingredients-usa.com/Industry/Nutraceutical-firm-targets-Chinese-window-of-opportunity
